President and Chief Executive Officer, Novo Nordisk
Appears in 1 story
Led company through Awiqli's approval
For 104 years, every insulin on the market has required at least one injection per day. On March 26, the FDA approved Awiqli, a once-weekly basal insulin from Novo Nordisk for adults with type 2 diabetes. That cuts basal insulin injections from 365 to 52 per year.
Updated May 30
No stories match your search
Try a different keyword
How would you like to describe your experience with the app today?
